3/19/2026 - 11:29 AM EST - Knight Therapeutics Inc. : Today reported financial results for its fourth quarter ended December 31, 2025. Revenues were $450,088, an increase of $78,784 or 21% over the prior year. Net loss was $5,374, compared to a net income of $4,332 in prior year.. Knight Therapeutics Inc.
shares T.GUD are trading up $0.05 at $6.22.
3/19/2026 - 10:38 AM EST - illumin Holdings Inc. : And Full Stack Big Data today announced a strategic partnership designed to help advertisers expand meaningful reach, reduce waste and turn more media spend into measurable performance while operating in a privacy-safe advertising environment. illumin Holdings Inc.
shares T.ILLM are trading unchanged at $0.82.
3/19/2026 - 10:10 AM EST - HEALWELL AI Inc. : Announced its audited consolidated financial results for the fourth quarter ended December 31, 2025. HEALWELL achieved record annual revenue from continuing operations of approximately $103.8 million in fiscal 2025, an increase of 427% compared to the $19.7 million in fiscal 2024. The Company reported an IFRS net loss from continuing operations of $39.1 million in fiscal 2025, compared to a net loss of $24 million in fiscal 2024. HEALWELL AI Inc.
shares T.AIDX are trading down $0.02 at $0.91.
3/19/2026 - 10:02 AM EST - Oncolytics Biotech Inc : Announced two abstracts across distinct tumor types were accepted for presentation at the American Association for Cancer Research Annual Meeting 2026, at the San Diego Convention Center from April 17-22, 2026. Pelareorep is an investigational, systemically delivered immunotherapy that has been shown to activate innate immune-sensing pathways via double-stranded RNA signaling, driving interferon production, dendritic cell activation, and cytotoxic T-cell priming. Oncolytics Biotech Inc
shares N.ONCY are trading off $0.01 at $0.95.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7811362759413847
3/19/2026 - 10:01 AM EST - NetraMarkHoldings Inc. : Announced new findings illustrating the ability of its proprietary explainable AI platform, NetraAI, to uncover clinically meaningful responder subgroups within the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. NetraMarkHoldings Inc.
shares T.AIAI are trading unchanged at $1.00.
3/19/2026 - 9:56 AM EST - PyroGenesis Inc. : Announces that Rio Tinto and Alcoa are presenting today, at the annual conference of The Minerals, Metals & Materials Society, data that confirms that PyroGenesis’ patented plasma torches provide significant reductions and/or cost savings in key operational metrics when compared to natural gas burners. PyroGenesis Inc.
shares T.PYR are trading up $0.08 at $0.58.
3/19/2026 - 9:52 AM EST - Sylogist Ltd. : Today announced its financial results for the three months ended December 31, 2025. Q4 SaaS ARR Bookings were up 8.1% Y/Y to $0.5 million. Its gross profit margin of 56%. Adjusted EBITDA margin was 7.2% or $1.0 million; and net loss of $0.9 million. Sylogist Ltd.
shares T.SYZ are trading down $0.07 at $3.80.
3/19/2026 - 9:48 AM EST - Tilray Brands, Inc. : Said its Tilray Medical brand announced its largest portfolio expansion in Australia to date. The expanded medical cannabis offering reinforces Tilray Medical’s long-term commitment to the Australian market and supports increased patient access to regulated, clinically supported medical cannabis products. Tilray Brands, Inc.
shares T.TLRY are trading down $0.30 at $8.97.
3/19/2026 - 9:42 AM EST - Aclara Resources Inc. : Announced that it intends to sell, on a non-brokered private placement basis, in two tranches, 24,215,548 common shares of the Company for aggregate gross proceeds of US$50,000,001 at a price of C$2.83 per share. Aclara Resources Inc.
shares T.ARA are trading unchanged at $3.22.
3/19/2026 - 9:37 AM EST - STORAGEVAULT CANADA INC. : Has received conditional acceptance from the Toronto Stock Exchange to conduct a Normal Course Issuer Bid to purchase for cancellation, during the 12-month period starting March 23, 2026. STORAGEVAULT CANADA INC.
shares T.SVI are trading unchanged at $4.50.
